(VIANEWS) – The Innrs Artificial Intelligence algorithm has been making predictions about the next day stock price and guessing some of them correctly.
We, at Via News, will follow this AI algorithm and publish the results every week day.
Yesterday’s AI prediction for today would produce a ROI of -0.63% if an investor was to invest following yesterday’s Innrs AI suggestion.
See the data in the table below.
| Financial Asset | Accuracy | Prediction | ROI |
|---|---|---|---|
| Franco (FNV) | 88.29% | $146.54 | 1.04% ✅ |
| Novartis AG (NVS) | 89.1% | $91.67 | 0.79% ✅ |
| Hasbro (HAS) | 88.43% | $51.39 | 0.78% ✅ |
| Mondelez International (MDLZ) | 89.15% | $69.49 | 0.61% ✅ |
| Eli Lilly and Company (LLY) | 87.79% | $348.14 | 0.6% ✅ |
| AbbVie (ABBV) | 89.11% | $160.44 | 0.43% ✅ |
| Biogen (BIIB) | 84.15% | $276.94 | 0.2% ✅ |
| Procter & Gamble (PG) | 88.79% | $151.61 | 0.2% ✅ |
| GlaxoSmithKline (GSK) | 88.62% | $35.69 | 0.17% ✅ |
| HCA Holdings (HCA) | 84.1% | $259.05 | -0.07% |
| Verizon (VZ) | 89.29% | $39.14 | -0.24% |
| Electronic Arts (EA) | 88.51% | $122.58 | -0.78% |
| Boston Beer Company (SAM) | 84.06% | $336.78 | -1.27% |
| Take-Two Interactive Software (TTWO) | 93.73% | $120.48 | -1.63% |
| Amerco (UHAL) | 88.07% | $51.37 | -2.01% |
| Match Group (MTCH) | 88.48% | $41.58 | -2.3% |
| Atrion (ATRI) | 88.44% | $651.67 | -2.36% |
| Ecopetrol S.A. (EC) | 87.52% | $9.82 | -2.5% |
| Ringcentral (RNG) | 85.33% | $25.15 | -3.71% |
1. Franco (FNV)
Franco has been having an accuracy rate of 88.29% over the last 10 sessions. Previous close price was $143.91 the AI prediction was $146.54 and today’s closing price was $145.41. The intraday ROI for Franco (FNV) was 1.04%.
Shares of Franco rose by a staggering 15.45% in from $126.05 to $145.52 at 22:29 EST on Tuesday, after two consecutive sessions in a row of gains. NYSE is jumping 0.37% to $14,949.35, after three successive sessions in a row of gains.
Franco-Nevada Corporation operates as a gold-focused royalty and streaming company in Latin America, the United States, Canada, and internationally.
Earnings Per Share
As for profitability, Franco has a trailing twelve months EPS of $1.71.
PE Ratio
Franco has a trailing twelve months price to earnings ratio of 85.1. Meaning, the purchaser of the share is investing $85.1 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.52%.
Sales Growth
Franco’s sales growth for the current quarter is negative 12.7%.
More news about Franco.
2. Novartis AG (NVS)
Novartis AG has been having an accuracy rate of 89.1% over the last 10 sessions. Previous close price was $90.24 the AI prediction was $91.67 and today’s closing price was $90.95. The intraday ROI for Novartis AG (NVS) was 0.79%.
Shares of Novartis AG jumped 6.31% in from $85.57 to $90.97 at 22:29 EST on Tuesday, after five successive sessions in a row of gains. NYSE is jumping 0.37% to $14,949.35, after three consecutive sessions in a row of gains.
Novartis AG researches, develops, manufactures, and markets healthcare products in Switzerland and internationally.
Earnings Per Share
As for profitability, Novartis AG has a trailing twelve months EPS of $3.48.
PE Ratio
Novartis AG has a trailing twelve months price to earnings ratio of 26.14. Meaning, the purchaser of the share is investing $26.14 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 10.93%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 3.2%, now sitting on 51.83B for the twelve trailing months.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Mar 8, 2023, the estimated forward annual dividend rate is 3.47 and the estimated forward annual dividend yield is 4.02%.
Yearly Top and Bottom Value
Novartis AG’s stock is valued at $90.97 at 22:29 EST, under its 52-week high of $94.26 and way above its 52-week low of $74.09.
More news about Novartis AG.
3. Hasbro (HAS)
Hasbro has been having an accuracy rate of 88.43% over the last 10 sessions. Previous close price was $50.09 the AI prediction was $51.39 and today’s closing price was $50.48. The intraday ROI for Hasbro (HAS) was 0.78%.
Shares of Hasbro dropped by a staggering 11.13% in from $56.73 to $50.42 at 22:29 EST on Tuesday, after three successive sessions in a row of gains. NASDAQ is dropping 0.45% to $11,716.08, after two successive sessions in a row of losses.
Hasbro, Inc., together with its subsidiaries, operates as a play and entertainment company.
Earnings Per Share
As for profitability, Hasbro has a trailing twelve months EPS of $2.97.
PE Ratio
Hasbro has a trailing twelve months price to earnings ratio of 17. Meaning, the purchaser of the share is investing $17 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.7%.
Moving Average
Hasbro’s worth is way under its 50-day moving average of $59.62 and way under its 200-day moving average of $69.98.
Growth Estimates Quarters
The company’s growth estimates for the ongoing quarter is 6.6% and a drop 14% for the next.
Dividend Yield
As stated by Morningstar, Inc., the next dividend payment is on Jan 30, 2023, the estimated forward annual dividend rate is 2.8 and the estimated forward annual dividend yield is 4.72%.
More news about Hasbro.
4. Mondelez International (MDLZ)
Mondelez International has been having an accuracy rate of 89.15% over the last 10 sessions. Previous close price was $69.17 the AI prediction was $69.49 and today’s closing price was $69.59. The intraday ROI for Mondelez International (MDLZ) was 0.61%.
Shares of Mondelez International rose 6% in from $65.66 to $69.60 at 22:29 EST on Tuesday, after three sequential sessions in a row of gains. NASDAQ is falling 0.45% to $11,716.08, after two consecutive sessions in a row of losses.
Mondelez International, Inc., through its subsidiaries, manufactures, markets, and sells snack food and beverage products in the Latin America, North America, Asia, the Middle East, Africa, and Europe.
Earnings Per Share
As for profitability, Mondelez International has a trailing twelve months EPS of $2.64.
PE Ratio
Mondelez International has a trailing twelve months price to earnings ratio of 26.36. Meaning, the purchaser of the share is investing $26.36 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 9.87%.
Dividend Yield
According to Morningstar, Inc., the next dividend payment is on Mar 29, 2023, the estimated forward annual dividend rate is 1.54 and the estimated forward annual dividend yield is 2.4%.
Moving Average
Mondelez International’s worth is above its 50-day moving average of $65.78 and above its 200-day moving average of $63.44.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Mondelez International’s stock is considered to be oversold (<=20).
Growth Estimates Quarters
The company’s growth estimates for the current quarter is a negative 3.6% and positive 4.5% for the next.
More news about Mondelez International.
5. Eli Lilly and Company (LLY)
Eli Lilly and Company has been having an accuracy rate of 87.79% over the last 10 sessions. Previous close price was $335.65 the AI prediction was $348.14 and today’s closing price was $337.65. The intraday ROI for Eli Lilly and Company (LLY) was 0.6%.
Shares of Eli Lilly and Company rose 6.3% in from $317.36 to $337.35 at 22:29 EST on Tuesday, following the last session’s upward trend. NYSE is rising 0.37% to $14,949.35, after three successive sessions in a row of gains.
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide.
Earnings Per Share
As for profitability, Eli Lilly and Company has a trailing twelve months EPS of $6.68.
PE Ratio
Eli Lilly and Company has a trailing twelve months price to earnings ratio of 50.5. Meaning, the purchaser of the share is investing $50.5 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 64.64%.
Volatility
Eli Lilly and Company’s last week, last month’s, and last quarter’s current intraday variation average was 0.40%, 0.47%, and 1.14%.
Eli Lilly and Company’s highest amplitude of average volatility was 0.63% (last week), 0.89% (last month), and 1.14% (last quarter).
Revenue Growth
Year-on-year quarterly revenue growth declined by 8.7%, now sitting on 28.54B for the twelve trailing months.
More news about Eli Lilly and Company.
6. AbbVie (ABBV)
AbbVie has been having an accuracy rate of 89.11% over the last 10 sessions. Previous close price was $157.58 the AI prediction was $160.44 and today’s closing price was $158.25. The intraday ROI for AbbVie (ABBV) was 0.43%.
Shares of AbbVie rose 2.78% in from $154.11 to $158.39 at 22:29 EST on Tuesday, following the last session’s upward trend. NYSE is jumping 0.37% to $14,949.35, after three successive sessions in a row of gains.
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide.
Earnings Per Share
As for profitability, AbbVie has a trailing twelve months EPS of $2.91.
PE Ratio
AbbVie has a trailing twelve months price to earnings ratio of 54.37. Meaning, the purchaser of the share is investing $54.37 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 90.65%.
Volatility
AbbVie’s last week, last month’s, and last quarter’s current intraday variation average was 0.74%, 0.07%, and 0.97%.
AbbVie’s highest amplitude of average volatility was 0.89% (last week), 0.96% (last month), and 0.97% (last quarter).
Volume
Today’s last reported volume for AbbVie is 2606690 which is 59.26% below its average volume of 6399770.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is a negative 5.7% and a negative 10.4%, respectively.
More news about AbbVie.
7. Biogen (BIIB)
Biogen has been having an accuracy rate of 84.15% over the last 10 sessions. Previous close price was $269.7 the AI prediction was $276.94 and today’s closing price was $270.25. The intraday ROI for Biogen (BIIB) was 0.2%.
Shares of Biogen rose 0.14% in from $270.36 to $270.74 at 22:29 EST on Tuesday, following the last session’s upward trend. NASDAQ is dropping 0.45% to $11,716.08, after two consecutive sessions in a row of losses.
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases.
Earnings Per Share
As for profitability, Biogen has a trailing twelve months EPS of $19.29.
PE Ratio
Biogen has a trailing twelve months price to earnings ratio of 14.03. Meaning, the purchaser of the share is investing $14.03 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 20.23%.
Moving Average
Biogen’s worth is under its 50-day moving average of $277.05 and above its 200-day moving average of $252.10.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 3.5% and 13.8%, respectively.
Volume
Today’s last reported volume for Biogen is 372768 which is 62.46% below its average volume of 993251.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Biogen’s stock is considered to be oversold (<=20).
More news about Biogen.
8. Procter & Gamble (PG)
Procter & Gamble has been having an accuracy rate of 88.79% over the last 10 sessions. Previous close price was $146.07 the AI prediction was $151.61 and today’s closing price was $146.36. The intraday ROI for Procter & Gamble (PG) was 0.2%.
Shares of Procter & Gamble rose 4.97% in from $139.18 to $146.10 at 22:29 EST on Tuesday, after two successive sessions in a row of gains. NYSE is jumping 0.37% to $14,949.35, after three successive sessions in a row of gains.
The Procter & Gamble Company provides branded consumer packaged goods worldwide.
Earnings Per Share
As for profitability, Procter & Gamble has a trailing twelve months EPS of $5.44.
PE Ratio
Procter & Gamble has a trailing twelve months price to earnings ratio of 26.86. Meaning, the purchaser of the share is investing $26.86 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 32.02%.
Sales Growth
Procter & Gamble’s sales growth is negative 0.5% for the present quarter and 1.8% for the next.
Revenue Growth
Year-on-year quarterly revenue growth declined by 0.9%, now sitting on 80.28B for the twelve trailing months.
Volatility
Procter & Gamble’s last week, last month’s, and last quarter’s current intraday variation average was 0.46%, 0.37%, and 0.84%.
Procter & Gamble’s highest amplitude of average volatility was 0.90% (last week), 0.88% (last month), and 0.84% (last quarter).
Moving Average
Procter & Gamble’s value is higher than its 50-day moving average of $141.30 and higher than its 200-day moving average of $141.41.
More news about Procter & Gamble.
9. GlaxoSmithKline (GSK)
GlaxoSmithKline has been having an accuracy rate of 88.62% over the last 10 sessions. Previous close price was $35.04 the AI prediction was $35.69 and today’s closing price was $35.1. The intraday ROI for GlaxoSmithKline (GSK) was 0.17%.
Shares of GlaxoSmithKline rose 0.8% in from $34.84 to $35.12 at 22:29 EST on Tuesday, after two sequential sessions in a row of gains. NYSE is jumping 0.37% to $14,949.35, after three consecutive sessions in a row of gains.
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally.
Earnings Per Share
As for profitability, GlaxoSmithKline has a trailing twelve months EPS of $2.88.
PE Ratio
GlaxoSmithKline has a trailing twelve months price to earnings ratio of 12.19. Meaning, the purchaser of the share is investing $12.19 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 31.31%.
Revenue Growth
Year-on-year quarterly revenue growth declined by 22.6%, now sitting on 29.32B for the twelve trailing months.
Moving Average
GlaxoSmithKline’s value is above its 50-day moving average of $34.96 and below its 200-day moving average of $35.71.
Volume
Today’s last reported volume for GlaxoSmithKline is 2882150 which is 21.85% below its average volume of 3688250.
More news about GlaxoSmithKline.
10. HCA Holdings (HCA)
HCA Holdings has been having an accuracy rate of 84.1% over the last 10 sessions. Previous close price was $254.67 the AI prediction was $259.05 and today’s closing price was $254.48. The intraday ROI for HCA Holdings (HCA) was -0.07%.
Shares of HCA Holdings rose 2.73% in from $247.99 to $254.76 at 22:29 EST on Tuesday, after three sequential sessions in a row of gains. NYSE is rising 0.37% to $14,949.35, after three successive sessions in a row of gains.
HCA Healthcare, Inc., through its subsidiaries, provides health care services company in the United States.
Earnings Per Share
As for profitability, HCA Holdings has a trailing twelve months EPS of $13.38.
PE Ratio
HCA Holdings has a trailing twelve months price to earnings ratio of 19.04. Meaning, the purchaser of the share is investing $19.04 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 965.25%.
More news about HCA Holdings.
11. Verizon (VZ)
Verizon has been having an accuracy rate of 89.29% over the last 10 sessions. Previous close price was $38.09 the AI prediction was $39.14 and today’s closing price was $38. The intraday ROI for Verizon (VZ) was -0.24%.
Shares of Verizon slid 2% in from $38.81 to $38.03 at 22:29 EST on Tuesday, after two consecutive sessions in a row of losses. NYSE is jumping 0.37% to $14,949.35, after three sequential sessions in a row of gains.
Verizon Communications Inc., through its subsidiaries, provides communications, technology, information, and entertainment products and services to consumers, businesses, and governmental entities worldwide.
Earnings Per Share
As for profitability, Verizon has a trailing twelve months EPS of $4.56.
PE Ratio
Verizon has a trailing twelve months price to earnings ratio of 8.34. Meaning, the purchaser of the share is investing $8.34 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 24.76%.
More news about Verizon.
12. Electronic Arts (EA)
Electronic Arts has been having an accuracy rate of 88.51% over the last 10 sessions. Previous close price was $118.95 the AI prediction was $122.58 and today’s closing price was $118.02. The intraday ROI for Electronic Arts (EA) was -0.78%.
Shares of Electronic Arts rose 6.56% in from $110.77 to $118.04 at 22:29 EST on Tuesday, after two sequential sessions in a row of losses. NASDAQ is dropping 0.45% to $11,716.08, after two consecutive sessions in a row of losses.
Electronic Arts Inc. develops, markets, publishes, and distributes games, content, and services for game consoles, PCs, mobile phones, and tablets worldwide.
Earnings Per Share
As for profitability, Electronic Arts has a trailing twelve months EPS of $4.05.
PE Ratio
Electronic Arts has a trailing twelve months price to earnings ratio of 29.18. Meaning, the purchaser of the share is investing $29.18 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 13.7%.
Volume
Today’s last reported volume for Electronic Arts is 1248900 which is 50.9% below its average volume of 2543820.
More news about Electronic Arts.
13. Boston Beer Company (SAM)
Boston Beer Company has been having an accuracy rate of 84.06% over the last 10 sessions. Previous close price was $328.25 the AI prediction was $336.78 and today’s closing price was $324.07. The intraday ROI for Boston Beer Company (SAM) was -1.27%.
Shares of Boston Beer Company slid 0.73% in from $327.24 to $324.85 at 22:29 EST on Tuesday, after two successive sessions in a row of losses. NYSE is rising 0.37% to $14,949.35, after three successive sessions in a row of gains.
The Boston Beer Company, Inc. produces and sells alcohol beverages primarily in the United States.
Earnings Per Share
As for profitability, Boston Beer Company has a trailing twelve months EPS of $19.29.
PE Ratio
Boston Beer Company has a trailing twelve months price to earnings ratio of 16.84. Meaning, the purchaser of the share is investing $16.84 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.56%.
Volume
Today’s last reported volume for Boston Beer Company is 66371 which is 57.47% below its average volume of 156063.
Yearly Top and Bottom Value
Boston Beer Company’s stock is valued at $324.85 at 22:29 EST, way under its 52-week high of $422.75 and way higher than its 52-week low of $287.00.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 118.5% and 756.2%, respectively.
More news about Boston Beer Company.
14. Take-Two Interactive Software (TTWO)
Take-Two Interactive Software has been having an accuracy rate of 93.73% over the last 10 sessions. Previous close price was $117.47 the AI prediction was $120.48 and today’s closing price was $115.55. The intraday ROI for Take-Two Interactive Software (TTWO) was -1.63%.
Shares of Take-Two Interactive Software jumped 4.38% in from $110.88 to $115.74 at 22:29 EST on Tuesday, after two consecutive sessions in a row of losses. NASDAQ is sliding 0.45% to $11,716.08, after two consecutive sessions in a row of losses.
Take-Two Interactive Software, Inc. develops, publishes, and markets interactive entertainment solutions for consumers worldwide.
Earnings Per Share
As for profitability, Take-Two Interactive Software has a trailing twelve months EPS of $4.27.
PE Ratio
Take-Two Interactive Software has a trailing twelve months price to earnings ratio of 27.11. Meaning, the purchaser of the share is investing $27.11 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -6.11%.
More news about Take-Two Interactive Software.
15. Amerco (UHAL)
Amerco has been having an accuracy rate of 88.07% over the last 10 sessions. Previous close price was $55.28 the AI prediction was $51.37 and today’s closing price was $56.39. The intraday ROI for Amerco (UHAL) was -2.01%.
Shares of Amerco fell by a staggering 14.7% in from $66.35 to $56.60 at 22:29 EST on Tuesday, after two sequential sessions in a row of gains. NASDAQ is falling 0.45% to $11,716.08, after two consecutive sessions in a row of losses.
U-Haul Holding Company operates as a do-it-yourself moving and storage operator for household and commercial goods in the United States and Canada.
Earnings Per Share
As for profitability, Amerco has a trailing twelve months EPS of $33.63.
PE Ratio
Amerco has a trailing twelve months price to earnings ratio of 1.68. Meaning, the purchaser of the share is investing $1.68 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 15.9%.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Amerco’s stock is considered to be oversold (<=20).
Moving Average
Amerco’s worth is way below its 50-day moving average of $63.67 and under its 200-day moving average of $56.73.
Revenue Growth
Year-on-year quarterly revenue growth declined by 2.1%, now sitting on 5.87B for the twelve trailing months.
More news about Amerco.
16. Match Group (MTCH)
Match Group has been having an accuracy rate of 88.48% over the last 10 sessions. Previous close price was $40.42 the AI prediction was $41.58 and today’s closing price was $39.49. The intraday ROI for Match Group (MTCH) was -2.3%.
Shares of Match Group dropped 6.66% in from $42.31 to $39.49 at 22:29 EST on Tuesday, following the last session’s downward trend. NASDAQ is falling 0.45% to $11,716.08, after two consecutive sessions in a row of losses.
Match Group, Inc. provides dating products worldwide.
Earnings Per Share
As for profitability, Match Group has a trailing twelve months EPS of $0.49.
PE Ratio
Match Group has a trailing twelve months price to earnings ratio of 80.93. Meaning, the purchaser of the share is investing $80.93 for every dollar of annual earnings.
Volatility
Match Group’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.39%, a negative 0.37%, and a positive 2.11%.
Match Group’s highest amplitude of average volatility was 1.24% (last week), 1.63% (last month), and 2.11% (last quarter).
Sales Growth
Match Group’s sales growth is negative 0.5% for the ongoing quarter and 4% for the next.
More news about Match Group.
17. Atrion (ATRI)
Atrion has been having an accuracy rate of 88.44% over the last 10 sessions. Previous close price was $634.99 the AI prediction was $651.67 and today’s closing price was $620. The intraday ROI for Atrion (ATRI) was -2.36%.
Shares of Atrion slid 6.52% in from $685.71 to $641.00 at 22:29 EST on Tuesday, after two successive sessions in a row of losses. NASDAQ is dropping 0.45% to $11,716.08, after two consecutive sessions in a row of losses.
Atrion Corporation, together with its subsidiaries, develops, manufactures, and sells products for fluid delivery, cardiovascular, and ophthalmology applications in the United States, Canada, Europe, and internationally.
Earnings Per Share
As for profitability, Atrion has a trailing twelve months EPS of $17.44.
PE Ratio
Atrion has a trailing twelve months price to earnings ratio of 36.75. Meaning, the purchaser of the share is investing $36.75 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.34%.
Revenue Growth
Year-on-year quarterly revenue growth grew by 4.1%, now sitting on 180.94M for the twelve trailing months.
Stock Price Classification
According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Atrion’s stock is considered to be overbought (>=80).
More news about Atrion.
18. Ecopetrol S.A. (EC)
Ecopetrol S.A. has been having an accuracy rate of 87.52% over the last 10 sessions. Previous close price was $10.02 the AI prediction was $9.82 and today’s closing price was $10.27. The intraday ROI for Ecopetrol S.A. (EC) was -2.5%.
Shares of Ecopetrol S.A. dropped 8.96% in from $11.28 to $10.27 at 22:29 EST on Tuesday, after four successive sessions in a row of gains. NYSE is jumping 0.37% to $14,949.35, after three sequential sessions in a row of gains.
Ecopetrol S.A. operates as an integrated energy company.
Earnings Per Share
As for profitability, Ecopetrol S.A. has a trailing twelve months EPS of $2.14.
PE Ratio
Ecopetrol S.A. has a trailing twelve months price to earnings ratio of 4.8. Meaning, the purchaser of the share is investing $4.8 for every dollar of annual earnings.
The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 34.49%.
Volume
Today’s last reported volume for Ecopetrol S.A. is 1210620 which is 47.81% below its average volume of 2319860.
Sales Growth
Ecopetrol S.A.’s sales growth is 59.4% for the current quarter and 26.6% for the next.
Dividend Yield
As claimed by Morningstar, Inc., the next dividend payment is on Apr 18, 2022, the estimated forward annual dividend rate is 1.49 and the estimated forward annual dividend yield is 14.2%.
Yearly Top and Bottom Value
Ecopetrol S.A.’s stock is valued at $10.27 at 22:29 EST, way below its 52-week high of $19.81 and way above its 52-week low of $8.59.
More news about Ecopetrol S.A..
19. Ringcentral (RNG)
Ringcentral has been having an accuracy rate of 85.33% over the last 10 sessions. Previous close price was $27.52 the AI prediction was $25.15 and today’s closing price was $28.54. The intraday ROI for Ringcentral (RNG) was -3.71%.
Shares of Ringcentral slid by a staggering 19.07% in from $35.18 to $28.47 at 22:29 EST on Tuesday, after four successive sessions in a row of gains. NYSE is rising 0.37% to $14,949.35, after three consecutive sessions in a row of gains.
RingCentral, Inc. provides software-as-a-service solutions that enable businesses to communicate, collaborate, and connect in North America.
Earnings Per Share
As for profitability, Ringcentral has a trailing twelve months EPS of $-0.94.
Yearly Top and Bottom Value
Ringcentral’s stock is valued at $28.47 at 22:29 EST, way under its 52-week high of $128.28 and higher than its 52-week low of $26.47.
Growth Estimates Quarters
The company’s growth estimates for the present quarter and the next is 51.3% and 61.5%, respectively.
Revenue Growth
Year-on-year quarterly revenue growth grew by 22.8%, now sitting on 1.91B for the twelve trailing months.
More news about Ringcentral.
